Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1141520220370060861
Endocrinology and Metabolism
2022 Volume.37 No. 6 p.861 ~ p.869
Efficacy and Safety of Long-Term Methimazole versus Radioactive Iodine in the Treatment of Toxic Multinodular Goiter
Azizi Fereidoun

Saadat Navid
Takyar Mir Alireza
Abdi Hengameh
Mehran Ladan
Amouzegar Atieh
Abstract
Background: This study compared the degree of sustained control of hyperthyroidism in patients with toxic multinodular goiter (TMNG) treated with long-term methimazole (LT-MMI) or radioactive iodine (RAI).

Methods: In this clinical trial, 130 untreated patients with TMNG were randomized to either LT-MMI or RAI treatment. Both groups were followed for 108 to 148 months, with median follow-up durations of 120 and 132 months in the LT-MMI and RAI groups, respectively. Both groups of patients were followed every 1 to 3 months in the first year and every 6 months thereafter.

Results: After excluding patients in whom the treatment modality was changed and those who were lost to follow-up, 53 patients in the LT-MMI group and 54 in the RAI group completed the study. At the end of the study period, 50 (96%) and 25 (46%) patients were euthyroid, and two (4%) and 25 (46%) were hypothyroid in LT-MMI and RAI groups, respectively. In the RAI group, four (8%) patients had subclinical hyperthyroidism. The mean time to euthyroidism was 4.3¡¾1.3 months in LT-MMI patients and 16.3¡¾ 15.0 months in RAI recipients (P<0.001). Patients treated with LT-MMI spent 95.8%¡¾5.9% of the 12-year study period in a euthyroid state, whereas this proportion was 72.4%¡¾14.8% in the RAI-treated patients (P<0.001). No major treatment-related adverse events were observed in either group.

Conclusion: In patients with TMNG, LT-MMI therapy is superior to RAI treatment, as shown by the earlier achievement of euthyroidism and the longer duration of sustained normal serum thyrotropin.
KEYWORD
Hyperthyroidism, Antithyroid, Methimazole, Iodine radioisotopes, Follow-up, Thyrotropin
FullTexts / Linksout information
Listed journal information
SCI(E) MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø